)--ProtoKinetix Inc. (OTCBB:PKTX) is pleased to announce their first commercial contract to manufacture and provide AAGP™ as the key active ingredient in a topical anti-inflammatory cream. This new product is expected to be launched within the next few months by the manufacturer of IB Relief, a leader in sports injury relief. The launch will be greatly enhanced by the use of proven channels of distribution to maximize their share of this multi-billion dollar market.
